Design of a potent, soluble glucokinase activator with excellent in vivo efficacy
- 1 May 2006
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (10), 2705-2709
- https://doi.org/10.1016/j.bmcl.2006.02.022
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte FunctionEndocrinology, 2005
- Type 2 diabetes marketNature Reviews Drug Discovery, 2005
- Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the YoungJournal of Biological Chemistry, 2005
- PDH kinase inhibitors: a novel therapy for Type II diabetes?Biochemical Society Transactions, 2005
- Glucokinase-activating ureasBioorganic & Medicinal Chemistry Letters, 2005
- Glucokinase and glucose homeostasis: proven concepts and new ideasBiochemical Society Transactions, 2005
- Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human GlucokinaseStructure, 2004
- Allosteric Activators of Glucokinase: Potential Role in Diabetes TherapyScience, 2003
- Insulin sensitisation in the treatment of Type 2 diabetesExpert Opinion on Investigational Drugs, 2003
- Regulation of Pancreatic β-Cell GlucokinaseDiabetes, 2002